SEOUL – Although the two companies seem to have different strategies, the ultimate purpose is the same: to focus on and accelerate expansion of their global businesses.
Daewoong Pharmaceutical Co. Ltd. said it will buy a 30.2% stake, equivalent to 15.5 million shares, in smaller rival...